| Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group MR Loken, TA Alonzo, L Pardo, RB Gerbing, SC Raimondi, BA Hirsch, ... Blood 120 (8), 1581-1588, 2012 | 309 | 2012 |
| Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML JA Pollard, TA Alonzo, RB Gerbing, PA Ho, R Zeng, Y Ravindranath, ... Blood 115 (12), 2372-2379, 2010 | 208 | 2010 |
| Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group PA Ho, TA Alonzo, RB Gerbing, J Pollard, DL Stirewalt, C Hurwitz, ... Blood 113 (26), 6558-6566, 2009 | 194 | 2009 |
| C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations JA Pulikkan, PS Peramangalam, V Dengler, PA Ho, C Preudhomme, ... Blood 116 (25), 5638-5649, 2010 | 162 | 2010 |
| Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients SB Keel, A Scott, M Sanchez-Bonilla, PA Ho, S Gulsuner, CC Pritchard, ... Haematologica 101 (11), 1343-1350, 2016 | 156 | 2016 |
| A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia EM Stein, RB Walter, HP Erba, AT Fathi, AS Advani, JE Lancet, F Ravandi, ... Blood 131 (4), 387-396, 2018 | 153 | 2018 |
| Leukemic mutations in the methylation‐associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group PA Ho, MA Kutny, TA Alonzo, RB Gerbing, J Joaquin, SC Raimondi, ... Pediatric blood & cancer 57 (2), 204-209, 2011 | 132 | 2011 |
| Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group PA Ho, R Zeng, TA Alonzo, RB Gerbing, KL Miller, JA Pollard, ... Blood 116 (5), 702-710, 2010 | 125 | 2010 |
| Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study PA Ho, TA Alonzo, KJ Kopecky, KL Miller, J Kuhn, R Zeng, RB Gerbing, ... Leukemia 24 (5), 909, 2010 | 112 | 2010 |
| Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML JA Pollard, TA Alonzo, M Loken, RB Gerbing, PA Ho, ID Bernstein, ... Blood 119 (16), 3705-3711, 2012 | 107 | 2012 |
| Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia K Tarlock, B Chang, T Cooper, T Gross, S Gupta, S Neudorf, K Adlard, ... Pediatric blood & cancer 62 (6), 1048-1054, 2015 | 73 | 2015 |
| A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML AT Fathi, HP Erba, JE Lancet, EM Stein, F Ravandi, S Faderl, RB Walter, ... Blood 132 (11), 1125-1133, 2018 | 69 | 2018 |
| WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute … PA Ho, J Kuhn, RB Gerbing, JA Pollard, R Zeng, KL Miller, NA Heerema, ... Journal of Clinical Oncology 29 (6), 704, 2011 | 69 | 2011 |
| Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report F Ostronoff, M Othus, PA Ho, M Kutny, DE Geraghty, SH Petersdorf, ... Leukemia 27 (1), 238, 2013 | 58 | 2013 |
| High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's … PA Ho, TA Alonzo, RB Gerbing, JA Pollard, B Hirsch, SC Raimondi, ... British journal of haematology 162 (5), 670-677, 2013 | 56 | 2013 |
| Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG PA Ho, KJ Kopecky, TA Alonzo, RB Gerbing, KL Miller, J Kuhn, R Zeng, ... Blood 118 (17), 4561-4566, 2011 | 56 | 2011 |
| High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the … RB Walter, TA Alonzo, RB Gerbing, PA Ho, FO Smith, SC Raimondi, ... Journal of Clinical Oncology 28 (17), 2831, 2010 | 44 | 2010 |
| FAM111B mutation is associated with inherited exocrine pancreatic dysfunction A Seo, T Walsh, M Lee, P Ho, EK Hsu, R Sidbury, MC King, A Shimamura Pancreas 45 (6), 858, 2016 | 43 | 2016 |
| Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group JN Berman, RB Gerbing, TA Alonzo, PA Ho, K Miller, C Hurwitz, ... Leukemia 25 (6), 1039, 2011 | 42 | 2011 |
| A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia. CM Zwaan, S Söderhäll, B Brethon, M Luciani, C Rizzari, RW Stam, ... British journal of haematology 185 (3), 623, 2019 | 32 | 2019 |
